Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-01, Stock:ABT, The news for the past five days is as follows:
2018-09-24: NEWS1: Why JNJ Stock Rose ~2.4% Last Week.NEWS2: Drug Stocks Rally Midday; Chinese Stocks Take a Hit.NEWS3: Why ABT Stock Is Trading at a Record High Today.NEWS4: A Look at Johnson & Johnson’s Valuation This Month.NEWS5: What Potential Do Analysts See for JNJ Stock?.NEWS6: Abbott Labs Rises 3.35%.NEWS7: Why Abbott (ABT) is Poised to Beat Earnings Estimates Again.NEWS8: Why Abbott (ABT) is Poised to Beat Earnings Estimates Again.NEWS9: Why Abbott (ABT) is Poised to Beat Earnings Estimates Again.NEWS10: Stocks Slump As Trade War Intensifies; 3 Med Stocks Rally, Tilray Tumbles.
2018-09-25: NEWS1: One-Year Results from Real-World Study Showed Abbott's Portico™ Transcatheter Aortic Valve Safely and Successfully Reduced Severe Aortic Stenosis.NEWS2: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Inflow.NEWS3: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Inflow.NEWS4: 5 Companies Hit 52-Week Highs.NEWS5: Abbott Laboratories Reaches Analyst Target Price.NEWS6: Abbott Laboratories Reaches Analyst Target Price.NEWS7: Bull of the Day: Penumbra (PEN).
2018-09-26: NEWS1: Abbott Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance.NEWS2: The trade on Abbott Labs, how oil will impact American Ai....NEWS3: Analyzing Perrigo’s Prescription Pharmaceuticals Business.
2018-09-27: NEWS1: A Look at Abbott Laboratories’ Valuation Trend.NEWS2: Analysts’ Most Recent Recommendations on ABT.NEWS3: Abbott Laboratories Continues Its Bull Run with a Record High.NEWS4: Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp.NEWS5: Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp.NEWS6: Abbott Labs' Test for Heart Attack Risk Granted With CE Mark.NEWS7: Abbott&apos;s Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp.NEWS8: New Research Coverage Highlights CyberArk Software, Mercer International, American Airlines Group, Abbott Laboratories, Open Text, and The Kroger — Consolidated Revenues, Company Growth, and Expectations for 2018.
2018-09-28: NEWS1: How Did Abbott Laboratories’s (NYSE:ABT) 2.7% ROE Fare Against The Industry?.NEWS2: High Valuation Multiples: Is EW Stock an Expensive Bet?.NEWS3: Edwards Lifesciences Stock: Most Analysts Are Bullish.NEWS4: EW Traded at Its 52-Week High on September 28.

Answer: Rise